Effects of liver-targeted drugs on expression of immune-related proteins in hepatocellular carcinoma cells
Conclusion Lenvatinib and regorafenib affected the expression of PD-L1 in the process of anti-HCC.
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
More News: Allergy & Immunology | Cancer | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver | Liver Cancer | Men | Study | Toxicology | Urology & Nephrology